SELLAS Life Sciences Group, Inc. Long-Term Debt
SELLAS Life Sciences Group, Inc. (SLS) had Long-Term Debt of $0 as of 2018-12-31, per its 10-K filed 2019-03-22.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2019-03-22
- 2018-12-31: Long-term Debt, Excluding Current Maturities $0.00.
- 2018-09-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2018-06-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2018-03-31: Long-term Debt, Excluding Current Maturities $1.15M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-22 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-14 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-14 |
| 2018-03-31 | $1.15M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $2.61M 10-K · filed 2019-03-22 |
| 2015-12-31 | $0.00 10-K/A · filed 2016-04-15 |
| 2015-09-30 | $1.53M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $2.55M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $3.53M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $4.49M 10-K/A · filed 2016-04-15 |
| 2014-09-30 | $5.10M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $6.00M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $6.88M 10-Q · filed 2014-05-06 |
| 2013-12-31 | $7.74M 8-K · filed 2015-12-04 |
| 2013-09-30 | $8.58M 10-Q/A · filed 2013-11-07 |
| 2013-06-30 | $9.40M 10-Q · filed 2013-08-09 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |